Office of the chief scientist
With high-level expertise in the main specific disease areas as well as in some important generic determinants of infectious diseases, the Office of the Chief Scientist drives the scientific agenda of the ECDC, and oversees the quality of the scientific output of the Centre.
The Office works in three sections:
1. Disease Programmes (Comprising the Heads of the seven Disease Programmes)
- Antimicrobial Resistance and Healthcare-associated Infections Programme;
- Emerging and Vector-borne Diseases Programme;
- Food- and Waterborne Diseases and Zoonoses Programme
- HIV, Sexually Transmitted Infections and viral Hepatitis;
- Influenza and other Respiratory Viruses Programme;
- Tuberculosis Programme; and
- Vaccine Preventable Diseases Programme.
2. Scientific Advice Coordination
- developing, maintaining, and improving the quality, consistency and transparency of the Centre’s scientific advice procedures and outputs;
- fostering information exchange between ECDC and European public health scientists/stakeholders on questions related to the scientific advice processes and research coordination; and ostering information exchange between ECDC and European public health scientists/stakeholders on questions related to the scientific advice processes and research coordination; and
- developing and promoting evidence-based methods and tools for public health, including burden of disease.
3. Microbiology Coordination
- striving to strengthen the capacity and capability of the EU public health microbiology system to provide timely and reliable information for infectious disease prevention and control at Member State and EU levels.
Additionally, responsibilities and resources for developing and maintaining an in-house programme to ascertain a high level of public health knowledge among the staff are based in this Office.
The Office builds its activities on close cooperation with the other Units, and not least on extensive networks with other scientific institutions and experts in the EU and globally.